XVIVO PERFUSION AB revenue for the last year amounted to 71.48 M EUR, the most of which — 34.37 M EUR — came from its highest performing source at the moment, Thoracic, the year earlier bringing 26.44 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought XVIVO PERFUSION AB 27.55 M EUR, and the year before that — 20.07 M EUR.